T-WIN
LIVE

Serial Number

87832891

Owner

IO Biotech ApS

Attorney

Melanie Howard

Filing Date

Mar 13, 2018

Add to watchlist:

No watchlists yet
View on USPTO

T-WIN Trademark

Serial Number: 87832891 • Registration: 5754675

T-WIN is a trademark filed by IO Biotech ApS on March 13, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

IO Biotech ApS (10 trademarks)

Ole Maaløes Vej 3

Entity Type: 99

Trademark Details

Filing Date

March 13, 2018

Registration Date

May 21, 2019

Published for Opposition

March 5, 2019

Goods & Services

Scientific research for medical purposes in the field of [ viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, ] oncological, [ hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system] related diseases; pharmaceutical drug research and development services; medical research services; pharmacological research services in the nature of pharmaceutical research; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the fields of pharmaceutical and clinical trials; conducting clinical trials for others; information, advisory and consultancy services relating to the aforesaid

[ Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; pharmaceutical drugs and pharmaceutical substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; synthetic peptides for pharmaceutical use for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; vaccines ]

Filing History

POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
Mar 10, 2026 PRAN
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Mar 9, 2026 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 9, 2026 C15P
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Mar 9, 2026 PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Feb 27, 2026 PR23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 27, 2026 APRE
TEAS SECTION 8 & 15 RECEIVED
Nov 21, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 21, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
May 21, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 5, 2019 NPUB
PUBLISHED FOR OPPOSITION
Mar 5, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 13, 2019 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Jan 29, 2019 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jan 25, 2019 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 19, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2018 CRFA
ASSIGNED TO LIE
Dec 6, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 30, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 23, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jun 23, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jun 23, 2018 CNRT
ASSIGNED TO EXAMINER
Jun 23, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2018 NWOS
NEW APPLICATION ENTERED
Mar 16, 2018 NWAP